NEW YORK (GenomeWeb News) – China's BGI said it has purchased 37 of Life Technologies' Ion Proton next-generation sequencing systems and will add at least 12 more machines by the end of the year.

Additionally, Shenzhen, China-based BGI said it has signed a supply and licensing agreement with Life Tech.

BGI will use the Proton for exome and transcriptome sequencing, as well as aneuploidy testing, according to a statement. The institution has already validated the Proton's PI chip, delivering 80 million reads in two- to three-hour sequencing runs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.